Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients

Erkens, J.A.; Klungel, O.H.; Herings, R.M.C.; Stolk, R.P.; Spoelstra, J.A.; Grobbee, D.E.; Leufkens, H.G.M.

Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients

DSpace/Manakin Repository

Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients

Erkens, J.A.; Klungel, O.H.; Herings, R.M.C.; Stolk, R.P.; Spoelstra, J.A.; Grobbee, D.E.; Leufkens, H.G.M.

(2002) European Heart Journal, volume 23, pp. 1575 - 1579

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Keywords: Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health

ISSN: 0195-668X

Publisher: Oxford University Press

(Peer reviewed)

See more statistics about this item